CPC
INDV icon

Cookson Peirce & Co’s Indivior Pharmaceuticals INDV Stock Holding History

Cookson Peirce & Co’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Buy
33,886
+11,175
+49% +$405K 0.05% 188
2026
Q1 		$692K Buy
+22,711
New +$750K 0.03% 211

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cookson Peirce & Co's INDV Position: Q2 2026 in Review

Cookson Peirce & Co increased its Indivior Pharmaceuticals (INDV) stake by 49% in Q2 2026, buying an estimated $405K and bringing the position to 33,886 shares worth $1.39M. The position accounts for 0.05% of the portfolio, ranked #188.

Cookson Peirce & Co first reported a position in INDV in Q1 2026 and has held it in 2 quarters since. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Cookson Peirce & Co held 33,886 shares of Indivior Pharmaceuticals worth $1.39M as of Q2 2026.
  • Cookson Peirce & Co bought 11,175 Indivior Pharmaceuticals shares in Q2 2026, an estimated $405K.
  • Indivior Pharmaceuticals made up 0.05% of Cookson Peirce & Co's portfolio in Q2 2026, its #188 holding.
  • Cookson Peirce & Co first reported a position in Indivior Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Cookson Peirce & Co's 13F filing for Q2 2026, filed 23 Jul 2026.